0001179110-19-001682.txt : 20190208
0001179110-19-001682.hdr.sgml : 20190208
20190208193538
ACCESSION NUMBER: 0001179110-19-001682
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190206
FILED AS OF DATE: 20190208
DATE AS OF CHANGE: 20190208
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Myer Vickesh
CENTRAL INDEX KEY: 0001742806
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37687
FILM NUMBER: 19581519
MAIL ADDRESS:
STREET 1: C/O EDITAS MEDICINE, INC.
STREET 2: 11 HURLEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Editas Medicine, Inc.
CENTRAL INDEX KEY: 0001650664
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 464097528
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11 HURLEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
BUSINESS PHONE: 617-401-9000
MAIL ADDRESS:
STREET 1: 11 HURLEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
4
1
edgar.xml
FORM 4 -
X0306
4
2019-02-06
0
0001650664
Editas Medicine, Inc.
EDIT
0001742806
Myer Vickesh
C/O EDITAS MEDICINE, INC.
11 HURLEY ST.
CAMBRIDGE
MA
02141
0
1
0
0
Chief Technology Officer
Stock Option (right to buy)
21.10
2019-02-06
4
A
0
48750
0
A
2029-02-05
Common Stock
48750
48750
D
Restricted Stock Units
2019-02-06
4
A
0
8125
0
A
Common Stock
8125
8125
D
This option was granted on February 6, 2019 and is scheduled to vest over four years in equal monthly installments beginning on February 6, 2019 through February 6, 2023.
Each restricted stock unit represents the right to receive one share of common stock of Editas Medicine, Inc.
The restricted stock unit award is scheduled to vest over four years with 25% of the units vesting on February 6, 2020 and the remaining 75% of the units scheduled to vest in equal quarterly installments thereafter through February 6, 2023. Shares will be delivered to the Reporting Person when units vest.
/s/ Vickesh Myer
2019-02-08